Quality of life assessment after concurrent chemoradiation for invasive bladder cancer: Results of a multicenter prospective study (getug 97-015)

International Journal of Radiation Oncology Biology Physics

Volumn 79, Issue 1, 2011, Pages 172-178

  Lagrange, Jean Léon ^a,b   Bascoul Mollevi, Caroline ^c   Geoffrois, Lionnel ^d   Beckendorf, Véronique ^d   Ferrero, Jean Marc ^b   Joly, Florence ^e   Allouache, Nedjila ^e   Bachaud, Jean Marc ^f   Chevreau, Christine ^f   Kramar, Andrew ^c   Chauvet, Bruno ^g  

^a HENRI MONDOR HOSPITAL   (France)

^b CENTRE ANTOINE LACASSAGNE   (France)

^c CENTRE VAL D AURELLE   (France)

^d CENTRE ALEXIS VAUTRIN   (France)

^e Centre Franois Baclesse   (France)

^f INSTITUT CLAUDIUS REGAUD   (France)

^g INSTITUT SAINTE CATHERINE   (France)

Author keywords

Bladder cancer; Chemotherapy; Organ preservation; Quality of life; Radiotherapy

Indexed keywords

5-FLUOROURACIL; AFTER-TREATMENT; BLADDER CANCERS; CIS-PLATIN; CONCURRENT CHEMORADIATION; CONCURRENT CHEMORADIOTHERAPY; CONCURRENT CHEMOTHERAPY; CONFIDENCE INTERVAL; LATE EFFECTS; NORMAL TISSUE; ORGAN PRESERVATION; OVERALL SURVIVAL; PELVIC IRRADIATION; PHASE II; PROSPECTIVE STUDY; QUALITY OF LIFE; RADICAL CYSTECTOMY; TRANSURETHRAL RESECTIONS; TUMOR CONTROL;

CHEMOTHERAPY; CONCURRENCY CONTROL; FUNCTION EVALUATION; PLATINUM COMPOUNDS; RADIOTHERAPY; RATING; SURGERY; TUMORS;

QUALITY CONTROL;

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CHEMORADIOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; FEMALE; FOLLOW UP; HUMAN; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; TRANSURETHRAL RESECTION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, TRANSITIONAL CELL; CISPLATIN; COMBINED MODALITY THERAPY; CYSTECTOMY; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; ORGAN PRESERVATION; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY DOSAGE; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 78650023934     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.10.038     Document Type: Article

References (23)

1. B. Chauvet, Y. Brewer, and C. Felix-Faure Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy J Urol 156 1996 1258 1262
2. B. Chauvet, C. Felix-Faure, and J.L. Davin [Treatment of infiltrating cancer of the bladder with cisplatin, fluorouracil, and concurrent radiotherapy: Results of a pilot study] Cancer Radiother 2 Suppl. 1 1998 77s 81s
3. B. Chauvet, C. Felix-Faure, and J.L. Davin [Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: Prognostic factors of local control and survival] Cancer Radiother 2 Suppl. 1 1998 85s 91s
4. A.L. Zietman, W.U. Shipley, and D.S. Kaufman The combination of cis-platin based chemotherapy and radiation in the treatment of muscle-invading transitional cell cancer of the bladder Int J Radiat Oncol Biol Phys 27 1993 161 170
5. A.L. Zietman, W.U. Shipley, and D.S. Kaufman A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer [see comments] J Urol 160 1998 1673 1677
6. R. Sauer, S. Birkenhake, and R. Kuhn Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer Int J Radiat Oncol Biol Phys 40 1998 121 127
7. A.L. Zietman, D. Sacco, and U. Skowronski Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: Results of a urodynamic and quality of life study on long-term survivors J Urol 170 2003 1772 1776
8. J.M. Herman, D.C. Smith, and J. Montie Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategy Urology 64 2004 69 73
9. RTOG/EORTC working groups LENT SOMA scales for all anatomic sites Int J Radiat Oncol Biol Phys 31 1995 1049 1091
10. N.K. Aaronson, S. Ahmedzai, and B. Bergman The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376
11. W.U. Shipley, D.S. Kaufman, and N.M. Heney Can chemo-radiotherapy plus transurethral tumor resection make cystectomy unnecessary for invasive bladder cancer? Oncology (Williston Park) 4 1990 25 32 discussion 32-24, 39
12. W.U. Shipley, D.S. Kaufman, and N.M. Heney An update of selective bladder preservation by combined modality therapy for invasive bladder cancer Eur Urol 33 1998 32 34
13. W.U. Shipley, D.S. Kaufman, and N.M. Heney An update of combined modality therapy for patients with muscle invading bladder cancer using selective bladder preservation or cystectomy J Urol 162 1999 445 450 discussion 450-451
14. M. Housset, B. Dufour, and C. Durdux [Concurrent radio-chemotherapy in infiltrating cancer of the bladder: a new therapeutic approach?] Cancer Radiother 2 Suppl. 1 1998 67s 72s (Pubitemid 28202043)
15. C. Rodel, G.G. Grabenbauer, and R. Kuhn Combined-modality treatment and selective organ preservation in invasive bladder cancer: Long-term results J Clin Oncol 20 2002 3061 3071
16. J. Dunst, C. Rodel, and A. Zietman Bladder preservation in muscle-invasive bladder cancer by conservative surgery and radiochemotherapy Semin Surg Oncol 20 2001 24 32
17. S. Mommsen, A. Jakobsen, and A. Sell Quality of life in patients with advanced bladder cancer. A randomized study comparing cystectomy and irradiation - the Danish Bladder Cancer Study Group (DAVECA protocol 8201) Scand J Urol Nephrol Suppl 125 1989 115 120
18. O. Caffo, G. Fellin, and U. Graffer Assessment of quality of life after cystectomy or conservative therapy for patients with infiltrating bladder carcinoma. A survey by a self-administered questionnaire Cancer 78 1996 1089 1097
19. M.P. Porter, and D.F. Penson Health related quality of life after radical cystectomy and urinary diversion for bladder cancer: A systematic review and critical analysis of the literature J Urol 173 2005 1318 1322
20. M.P. Porter, J.T. Wei, and D.F. Penson Quality of life issues in bladder cancer patients following cystectomy and urinary diversion Urol Clin North Am 32 2005 207 216
21. A. Zietman, and E. Skinner Quality of life after radical treatment for invasive bladder cancer Semin Radiat Oncol 15 2005 55 59
22. J. Hardt, D. Filipas, and R. Hohenfellner Quality of life in patients with bladder carcinoma after cystectomy: First results of a prospective study Qual Life Res 9 2000 1 12
23. L. Henningsohn, H. Wijkstrom, and P.W. Dickman Distressful symptoms after radical radiotherapy for urinary bladder cancer Radiother Oncol 62 2002 215 225